SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-015138
Filing Date
2018-11-08
Accepted
2018-11-08 13:39:43
Documents
15
Period of Report
2018-11-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k110818_xtlbiopharma.htm 6-K 11282
2 XTL BIOPHARMACEUTICALS LTD. INVESTOR PRESENTATION f6k110818ex99-1_xtlbio.htm EX-99.1 16167
3 GRAPHIC ex99-1_001.jpg GRAPHIC 249572
4 GRAPHIC ex99-1_002.jpg GRAPHIC 458180
5 GRAPHIC ex99-1_003.jpg GRAPHIC 202523
6 GRAPHIC ex99-1_004.jpg GRAPHIC 316673
7 GRAPHIC ex99-1_005.jpg GRAPHIC 217266
8 GRAPHIC ex99-1_006.jpg GRAPHIC 223549
9 GRAPHIC ex99-1_007.jpg GRAPHIC 245801
10 GRAPHIC ex99-1_008.jpg GRAPHIC 230605
11 GRAPHIC ex99-1_009.jpg GRAPHIC 227451
12 GRAPHIC ex99-1_010.jpg GRAPHIC 252637
13 GRAPHIC ex99-1_011.jpg GRAPHIC 349449
14 GRAPHIC ex99-1_012.jpg GRAPHIC 202596
15 GRAPHIC ex99-1_013.jpg GRAPHIC 172863
  Complete submission text file 0001213900-18-015138.txt   4642575
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 181169152
SIC: 2834 Pharmaceutical Preparations